Trial Profile
Phase 2 study of CCX872 in patients with Pancreatic cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Aug 2016
Price :
$35
*
At a glance
- Drugs CCX 872 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 04 Aug 2016 New trial record